Document is current

Any future updates will be listed below

ABT-126 monotherapy in mild-to-moderate Alzheimer’s dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension

Crossref DOI link: https://doi.org/10.1186/s13195-016-0210-1

Published Online: 2016-10-18

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark